Alpha Cognition Inc. Earnings Per Share (Basic)
Alpha Cognition Inc. (ACOG) reported Earnings Per Share (Basic) of -$0.40 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-13
- Alpha Cognition Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.40.
- Alpha Cognition Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.30.
- Alpha Cognition Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$0.30.
- Alpha Cognition Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.08.
- Alpha Cognition Inc. earnings per share, basic for fiscal 2025 was -$1.17.
- Alpha Cognition Inc. earnings per share, basic for fiscal 2024 was -$2.04.
- Alpha Cognition Inc. earnings per share, basic for fiscal 2023 was -$3.84.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.40 10-Q · filed 2026-08-13 | -$0.70 10-Q · filed 2026-08-13 | |||||
| 2026-03-31 | -$0.30 10-Q · filed 2026-05-14 | ||||||
| 2025-12-31 | -$0.30 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$0.42 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$1.02 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$1.17 10-K · filed 2026-03-31 | |||
| 2025-09-30 | -$0.08 10-Q · filed 2025-11-13 | -$0.73 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$0.86 10-Q · filed 2025-11-13 | -$1.32 derived: net income ÷ weighted average shares · filed 2026-08-13 | |||
| 2025-06-30 | -$0.82 10-Q · filed 2026-08-13 | -$0.65 10-Q · filed 2025-08-14 | -$0.93 10-Q · filed 2026-08-13 | -$0.78 10-Q · filed 2025-08-14 | -$1.27 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$1.64 derived: net income ÷ weighted average shares · filed 2026-08-13 | |
| 2025-03-31 | -$0.11 10-Q · filed 2026-05-14 | -$0.13 10-Q · filed 2025-05-15 | -$0.57 derived: net income ÷ weighted average shares · filed 2026-05-14 | -$0.87 derived: net income ÷ weighted average shares · filed 2026-05-14 | -$1.20 derived: net income ÷ weighted average shares · filed 2026-05-14 | ||
| 2024-12-31 | -$0.52 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$0.89 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$1.26 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$2.04 10-K · filed 2026-03-31 | -$2.02 10-K · filed 2025-03-31 | ||
| 2024-09-30 | -$0.31 10-Q · filed 2025-11-13 | -$0.66 derived: net income ÷ weighted average shares · filed 2025-11-13 | -$1.51 10-Q · filed 2025-11-13 | -$2.76 derived: net income ÷ weighted average shares · filed 2025-11-13 | |||
| 2024-06-30 | -$0.35 10-Q · filed 2025-08-14 | -$0.01 10-Q · filed 2024-08-12 | -$1.21 10-Q · filed 2025-08-14 | -$0.05 10-Q · filed 2024-08-12 | -$2.52 derived: net income ÷ weighted average shares · filed 2025-08-14 | -$3.36 derived: net income ÷ weighted average shares · filed 2025-08-14 | |
| 2024-03-31 | -$0.87 10-Q · filed 2025-05-15 | -$2.31 derived: net income ÷ weighted average shares · filed 2025-05-15 | -$3.19 derived: net income ÷ weighted average shares · filed 2025-05-15 | ||||
| 2023-12-31 | -$1.61 derived: net income ÷ weighted average shares · filed 2025-03-31 | -$2.42 derived: net income ÷ weighted average shares · filed 2025-03-31 | -$3.84 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | -$0.84 10-Q · filed 2024-11-14 | -$2.23 10-Q · filed 2024-11-14 | |||||
| 2023-06-30 | -$0.03 10-Q · filed 2024-08-12 | -$0.05 10-Q · filed 2024-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |